Bcl-xL as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in BRAF-mutant stage II and III colon cancer
暂无分享，去创建一个
Alan R Gilmore | P. Bankhead | P. Johnston | D. Longley | D. McArt | P. Dunne | S. Tejpar | F. Di Nicolantonio | M. Lawler | J. James | S. McQuaid | C. Holohan | D. Klingbiel | H. Coleman | V. Bingham | M. Loughrey | M. Alderdice | R. Gray | Amy M. B. McCorry